Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

TORONTO, April 03, 2023 (GLOBE NEWSWIRE) — Psyence Group inc. (CSE:PSYG | OTCQB:PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that it has issued 9,043,038 common shares at a price of CAD$0.12 per common share for gross proceeds of CAD$1,085,164. This brings the total…


The product has been added to your cart.

Continue shopping View Cart